FDANonrulemakingFDA-2016-D-4318
Who commented on this docket
Compounding and Repackaging of Radiopharmaceuticals By State-Licensed Nuclear Pharmacies and Federal Facilities; Draft Guidance for Industry; Availability
6 organizations filed 6 public comments on Compounding and Repackaging of Radiopharmaceuticals By State-Licensed Nuclear Pharmacies and Federal Facilities; Draft Guidance for Industry; Availability, at the Food and Drug Administration. The comment window closed 2904d ago.
Organizations
6
Comments
6
RIN
—
Comment window
closed 2904d ago
Commenters (6)
- American Pharmacists Association (APhA)trade assoc.1 filing · confidence 97%
- Council on Radionuclides and Radiopharmaceuticals CORARtrade assoc.1 filing · confidence 85%
- GE Healthcare Incunverified attribution1 filing · confidence 70%
- National Association of Nuclear Pharmaciestrade assoc.1 filing · confidence 85%
- Society of Nuclear Medicine and Molecular Imagingtrade assoc.1 filing · confidence 85%
- UPPI LLCunverified attribution1 filing · confidence 70%
Attribution is name-based and imperfect. regulations.gov data is public record.